Patient Journey Map: Metal Hypersensitivity
In this study, we highlight patients’ experiences with metal hypersensitivity (MH) after receiving implantable medical devices (IMDs). We aim to identify gaps in clinical care and improve outcomes for individuals who have or may be sensitive to metals. Secondary data analysis from a previous interpr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-06-01
|
| Series: | Journal of Patient Experience |
| Online Access: | https://doi.org/10.1177/23743735231183576 |
| _version_ | 1827920856591892480 |
|---|---|
| author | J. Adrienne Lagura RN, MN-NP (candidate) Dzifa Dordunoo RN, PhD Anastasia Mallidou RN, PhD Jett Carey BScN Elizabeth M. Borycki RN, PhD Andre Kushniruk BSc, PhD |
| author_facet | J. Adrienne Lagura RN, MN-NP (candidate) Dzifa Dordunoo RN, PhD Anastasia Mallidou RN, PhD Jett Carey BScN Elizabeth M. Borycki RN, PhD Andre Kushniruk BSc, PhD |
| author_sort | J. Adrienne Lagura RN, MN-NP (candidate) |
| collection | DOAJ |
| description | In this study, we highlight patients’ experiences with metal hypersensitivity (MH) after receiving implantable medical devices (IMDs). We aim to identify gaps in clinical care and improve outcomes for individuals who have or may be sensitive to metals. Secondary data analysis from a previous interpretative phenomenological qualitative study was utilized. Using patient journey maps, we explored the experiences of 8 individuals from outpatient settings who received IMD and have first-hand experience with MH. We documented their journey from MH symptom recognition to diagnosis and subsequent IMD management. The results reveal that the time frames from device implantation to the treatment of MH varied from 17 to 228 months. The longest phase on the patient journey maps was the symptom recognition phase, which refers to the time between symptom emergence and MH diagnosis. Participants also required extensive healthcare utilization following their initial surgery. These findings emphasize that MH should be considered in differential diagnoses for patients with IMD. Early screening and detection of MH can enhance patient safety, alleviate distress, and reduce unnecessary healthcare utilization. |
| first_indexed | 2024-03-13T04:17:44Z |
| format | Article |
| id | doaj.art-6fabd0d86e8f4bc0ade13a7a7e9c5f3c |
| institution | Directory Open Access Journal |
| issn | 2374-3743 |
| language | English |
| last_indexed | 2024-03-13T04:17:44Z |
| publishDate | 2023-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Journal of Patient Experience |
| spelling | doaj.art-6fabd0d86e8f4bc0ade13a7a7e9c5f3c2023-06-20T18:34:30ZengSAGE PublishingJournal of Patient Experience2374-37432023-06-011010.1177/23743735231183576Patient Journey Map: Metal HypersensitivityJ. Adrienne Lagura RN, MN-NP (candidate)0Dzifa Dordunoo RN, PhD1Anastasia Mallidou RN, PhD2Jett Carey BScN3Elizabeth M. Borycki RN, PhD4Andre Kushniruk BSc, PhD5 School of Nursing, University of Victoria, Victoria, Canada School of Nursing, University of Victoria, Victoria, Canada School of Nursing, University of Victoria, Victoria, Canada School of Nursing, University of Victoria, Victoria, Canada , Victoria, BC, Canada School of Nursing, University of Victoria, Victoria, CanadaIn this study, we highlight patients’ experiences with metal hypersensitivity (MH) after receiving implantable medical devices (IMDs). We aim to identify gaps in clinical care and improve outcomes for individuals who have or may be sensitive to metals. Secondary data analysis from a previous interpretative phenomenological qualitative study was utilized. Using patient journey maps, we explored the experiences of 8 individuals from outpatient settings who received IMD and have first-hand experience with MH. We documented their journey from MH symptom recognition to diagnosis and subsequent IMD management. The results reveal that the time frames from device implantation to the treatment of MH varied from 17 to 228 months. The longest phase on the patient journey maps was the symptom recognition phase, which refers to the time between symptom emergence and MH diagnosis. Participants also required extensive healthcare utilization following their initial surgery. These findings emphasize that MH should be considered in differential diagnoses for patients with IMD. Early screening and detection of MH can enhance patient safety, alleviate distress, and reduce unnecessary healthcare utilization.https://doi.org/10.1177/23743735231183576 |
| spellingShingle | J. Adrienne Lagura RN, MN-NP (candidate) Dzifa Dordunoo RN, PhD Anastasia Mallidou RN, PhD Jett Carey BScN Elizabeth M. Borycki RN, PhD Andre Kushniruk BSc, PhD Patient Journey Map: Metal Hypersensitivity Journal of Patient Experience |
| title | Patient Journey Map: Metal Hypersensitivity |
| title_full | Patient Journey Map: Metal Hypersensitivity |
| title_fullStr | Patient Journey Map: Metal Hypersensitivity |
| title_full_unstemmed | Patient Journey Map: Metal Hypersensitivity |
| title_short | Patient Journey Map: Metal Hypersensitivity |
| title_sort | patient journey map metal hypersensitivity |
| url | https://doi.org/10.1177/23743735231183576 |
| work_keys_str_mv | AT jadriennelagurarnmnnpcandidate patientjourneymapmetalhypersensitivity AT dzifadordunoornphd patientjourneymapmetalhypersensitivity AT anastasiamallidournphd patientjourneymapmetalhypersensitivity AT jettcareybscn patientjourneymapmetalhypersensitivity AT elizabethmboryckirnphd patientjourneymapmetalhypersensitivity AT andrekushnirukbscphd patientjourneymapmetalhypersensitivity |